Insilico Medicine develops novel PTPN2/N1 inhibitor for cancer immunotherapy using generative AI
In recent years, cancer immunotherapy, exemplified by PD-1 and its ligand PD-L1 blockade, has made remarkable advances. But while immunotherapy...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
In recent years, cancer immunotherapy, exemplified by PD-1 and its ligand PD-L1 blockade, has made remarkable advances. But while immunotherapy...
Scientists at Duke-NUS Medical School have uncovered why some pancreatic and colorectal cancers fail to respond to Wnt inhibitors, a...
The meeting point of the stomach and esophagus, the so-called gastro-esophageal junction, is a region of the human body that...
Researchers have unveiled a microfluidic device that significantly improves the separation of tumor cells and clusters from malignant effusions. This...
Laura Soucek, an ICREA Research Professor, Director of VHIO’s Experimental Therapeutics Program, and Head of our Models of Cancer Therapies...
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—hosted more than 1,700 oncology professionals...
MIAMI (April 11, 2024) – Researchers have developed a functional precision medicine approach that targets cancer by combining genetic testing with...
COLUMBUS, Ohio – Although lung cancer is traditionally thought of as a “smoker’s disease,” a surprising 15-20% of newly diagnosed...
“Our results reveal that MIA-602 may be a useful treatment for Doxorubicin-resistant AML ”Credit: 2024 Gaumond et al. “Our results...
(MEMPHIS, Tenn. – April 10, 2024) Infection with the influenza virus leads to lung injury through inflammation over-activation that causes...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine